Guru Fundamental Report for NKE

Validea's analysis of NIKE INC (NKE) using a Benjamin Graham deep value model resulted in a 71% score, indicating moderate alignment. While the large-cap growth stock passed fundamental health checks like long-term EPS growth, sales, and debt ratios, it notably failed on critical valuation metrics including Price/Earnings and Price/Book ratios, which are central to Graham's methodology, suggesting it is not a strong deep value play despite its overall financial health.

Analysis

According to a Validea fundamental report, NIKE INC (NKE) presents a conflicting profile when assessed against Benjamin Graham's deep value investment model. The company achieves a score of 71%, which is below the 80% threshold typically indicating model interest. While NKE demonstrates fundamental financial health by passing tests for sales volume, current ratio, long-term EPS growth, and maintaining low long-term debt relative to net current assets, it fails on key valuation metrics. Specifically, its Price/Earnings and Price/Book ratios are too high to meet the strict criteria of the Graham strategy. This suggests that while NKE is a fundamentally sound large-cap growth company, its current market valuation prevents it from being classified as a compelling deep value opportunity under this specific analytical framework, a conclusion supported by the neutral-to-negative sentiment score of -0.1.

Key Decisions for Investors

• Strict value investors following a Graham-style methodology should view NKE with caution, as its high P/E and P/B ratios are significant disqualifiers according to the model's core tenets.
• Investors with a growth or 'quality' focus may still find the stock's strong fundamentals, particularly its long-term EPS growth and healthy balance sheet, to be attractive despite the premium valuation.
• A potential entry point for value-oriented portfolios could emerge if a market pullback significantly lowers NKE's valuation multiples without a corresponding deterioration in its underlying financial health.
• Consider this analysis as a single data point from a specific deep value screen; it highlights a valuation concern but does not negate the company's demonstrated operational strengths.